News

SealingTech Unveils Innovative Cyber Defense Solutions for Enterprises

SealingTech Unveils Innovative Cyber Defense Solutions for Enterprises

SealingTech Launches Cutting-Edge Edge Computing Nodes

Sealing Technologies, a key player within Parsons Corporation (NYSE: PSN), is thrilled to announce the introduction of its advanced edge computing nodes: the GN 7100 and GN 9000. These innovative solutions are specifically designed to strengthen defensive cyber operations, supporting U.S. national security missions through enhanced operational capabilities and memory speeds.

Transforming Processing Speeds with Advanced Technology

The GN 7100 leverages the power of PCIe Gen 5 technology along with AMD's latest 9000 EPYC series processors. This combination facilitates unprecedented processing speeds, crucial for the demands of artificial intelligence (AI) and machine learning (ML). Cyber protection teams can now harness a high-performance GPU that greatly enhances their ability to manage demanding workloads right at the edge.

Innovative AI Capabilities

One of the standout features of the GN 7100 and GN 9000 is their ability to deliver scalable, deployable AI and ML functionalities that were previously confined to traditional data centers. This transformation allows organizations to operate with enhanced efficiency and agility, reflecting the modern needs of cybersecurity.

Enhancements Offered by the GN 9000

Moving to the GN 9000, this model elevates the performance of field operators significantly. Equipped with dual GPUs, the GN 9000 ensures maximum resource pooling for AI applications. It boasts an impressive 188GB of HBM3 memory, making it ideal for supporting the most demanding AI models directly at the point of operation. This innovative, carry-on-compliant design guarantees optimal operational effectiveness and increased storage capacity.

Meeting Future Needs in Cyber Defense

Brad Hatcher, Chief Product Officer at SealingTech, emphasizes the flexibility and scalability built into these new solutions. He notes, "The GN 7100 and GN 9000 are next-generation deployable solutions that deliver AI and ML capabilities ideally suited to meet the needs of today’s warfighters. These advancements will ensure that our customers have sufficient operational and storage capacity right where it is needed most — at the edge of the battlefield."

Collaborative Solutions for Cyber Security

SealingTech prides itself on its collaborative approach to developing defensive cyber solutions tailored to the distinct needs of its customers. The launch of the GN 7100 and GN 9000 demonstrates the company’s commitment to providing enhanced capabilities and greater value in the face of evolving threats.

About Sealing Technologies

Sealing Technologies (SealingTech), part of Parsons Corporation (NYSE: PSN), is recognized for delivering powerful edge computing hardware and cybersecurity solutions to safeguard federal agencies and private sectors alike. Founded by veterans, SealingTech capitalizes on extensive experience in cyberspace to offer pioneering research, engineering, and integration services, ensuring robust defense for the U.S. and its global partners. For additional insights visit www.sealingtech.com.

Frequently Asked Questions

What are the new products launched by SealingTech?

SealingTech has launched two new edge computing nodes, the GN 7100 and GN 9000, designed for advanced defensive cyber operations.

How do these new products enhance operational capabilities?

Both nodes offer faster processing speeds, customizable capabilities, and significant AI and ML functionalities, increasing efficiency for cyber protection teams.

What is the significance of the GN 9000?

The GN 9000 includes dual GPUs and provides extensive memory capacity, designed to manage the most demanding AI applications at the edge of operations.

Who is SealingTech's primary customer base?

SealingTech primarily serves federal government entities and private enterprises requiring tailored defensive cybersecurity solutions.

How can customers learn more about SealingTech's offerings?

Customers can visit SealingTech's official website to view detailed information regarding their products and services.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

PARRIS Law Firm Triumphs in Landmark Billing Case Against Edison

Updated Category News Views 258

PARRIS Law Firm Achieves Major Victory in Consumer Lawsuit The PARRIS Law Firm has recently celebrated a significant win for consumers in a landmark lawsuit against Southern California Edison Company. This case, referencing the Wellman v. Southern California Edison Company, has captured media attention, notably from The Daily Journal, showcasing the firm’s commitment to...

Continue Reading
Intercont (Cayman) Limited's Growth: Exploring Recent Financials

Updated Category News Views 112

Intercont (Cayman) Limited Unveils Financial Results Intercont (Cayman) Limited (NASDAQ: NCT), a prominent leader in the global shipping industry, has shared its financial results for the first half of the fiscal year. The company, renowned for its innovative approach to seaborne pulping operations, reported notable advancements in its financial performance, reflecting...

Continue Reading
What to Expect from Quanex Building Products' Earnings Report

Updated Category News Views 107

Understanding the Upcoming Earnings of Quanex Building Products Quanex Building Products (NASDAQ: NX) is gearing up to announce its quarterly earnings. This moment has been highly anticipated by investors eager to gain insights into the company's financial health. While specific dates are typically essential to focus on, the critical takeaway for investors is the...

Continue Reading
ZERO Fresh Start: RAVEN2's New Era Begins Sept 15

Updated Category News Views 18

What's the Big Deal with ZERO? Alright, so here we go, folks—Netmarble's strapping in with their latest server for RAVEN2, and it's called ZERO. Ever heard of fresh starts? ZERO is exactly that. This isn't your usual server shuffle. Lads and ladies who've felt the grind’ll tell you, ZERO's introducing a slew of changes you might want to sit up for. Pre-registration's...

Continue Reading
Innovative Cancer Treatments: CMU and Healthcare System Lead the Way

Updated Category News Views 266

Revolutionizing Cancer Treatment China Medical University (CMU) and Healthcare System are making significant strides in the field of cancer treatment, notably through AI-driven drug discovery and innovative therapies. At a recent healthcare exposition, these organizations showcased their leading-edge advancements, establishing themselves as pioneers in healthcare...

Continue Reading